HER2 Vaccine for Locally Advanced Breast Cancer

Clinical trial NCT06949410 · RECRUITING

Trial details

NCT number: NCT06949410
Sponsor: Pravin T.P Kaumaya
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer HER2-positive Breast Cancer

Start date: 2026-06-01
Primary completion: 2029-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.